In February, DMTC returned to Canberra for its 2024 Annual Conference.
Bringing together individuals from across the defence innovation and science & technology ecosystems, the aim of this year’s Annual Conference was to highlight significant advancements in Australia’s sovereign industrial capability while celebrating the collaborative efforts of individuals, teams and partners from across DMTC’s diverse portfolio of programs and projects.
The Conference also served as a forum for broader strategic discussions, including reflections on the implications of the Defence Strategic Review and associated initiatives, how stakeholders can best manage this period of transition and uncertainty, and overcoming the practical hurdles confronting the defence sector in delivering asymmetric capability.
The CEO of Australian biotech company Sementis Limited, Dr Anne Collins, has been honoured with the Collaboration Award at the DMTC Annual Conference for 2024.
Often described as the MVP Award, the Collaboration Award honours a leader who embodies the spirit of collaboration that is integral to DMTC’s strategic intent and outlook.
Health Security Systems Australia (HSSA) has confirmed plans for the impending transition of the division’s leadership.
Dr Leigh Farrell, who has been involved with DMTC since 2015 and has led the division since its establishment in mid-2021, will soon step down from a full-time role and continue with the Division in an advisory capacity. (more…)
DMTC’s 2023 Annual Report has been released in digital format, pending the arrival of hard copies of the report.
DMTC is proud of our partner group’s efforts to advance significant technology development and transfer initiatives, many of which are highlighted in the report. (more…)
